Human epidermal growth factor receptor 2 (HER2), a well-known breast cancer marker, could be detected using the colorimetric immunoassay with a limit of detection of 1.5 ng/mL, which was much lower than its clinical cutoff value (15 ng mL−1). Here, ERBB2 is linked to breast cancer.